Dauch Corporation (NYSE: DCH) reports full third-quarter results on November 6, 2026. Value writer Colin King (@valuedontlie) has stayed long through a BofA downgrade and a soft tape, calling Dauch his favorite asymmetric special situation. Preliminary company figures already sketch Adj. EBITDA of $355 million to $360 million and a narrower full-year band. We check whether the $300 million synergy plan still clears the debt.
This is journalism and commentary, not investment advice. We hold no position unless stated.
Key facts
- Ticker and exchange: Dauch Corporation, DCH, NYSE (also London).
- Situation type: Post-merger special situation in a levered auto supplier.
- The call: Colin King is long DCH; October 24, 2026 he rebutted a BofA cut by pointing to about $300 million of guided cost synergies.
- Price: DCH closed at $4.63 on October 23, 2026 (last close before that post) and about $4.53 on November 5, 2026.
- Preliminary Q3 (company 8-K, October 30, 2026): Net loss $42 million to $47 million; Adjusted EBITDA $355 million to $360 million.
- FY26 guide update: Sales $10.8 billion to $10.875 billion; Adjusted EBITDA cut to $1.350 billion to $1.375 billion from $1.360 billion to $1.425 billion.
- Synergies (Q2 update): About $70 million run-rate versus a more-than-$100 million year-one goal and $300 million by end of year three.
- Full print: Conference call 10:00 a.m. ET November 6, 2026.
What changed into the print?
King's October 16 reply to the BofA Underperform/$5 target cut was blunt: he was long and called the cut steep. His October 24 follow-up said the downgrade looked Q3-focused and pointed to $300 million of guided cost synergies from the February 2026 merger - about $1.25 a share pre-tax on a then ~$4.60 stock by his framing.
Dauch's October 30 Form 8-K then previewed Q3 Adj. EBITDA of $355 million to $360 million and cut the full-year Adj. EBITDA range to $1.350 billion to $1.375 billion, citing customer production volatility, inflation and energy costs. Sales guidance moved up slightly on metal pass-throughs. That is the tape King's synergy long has to clear on November 6.
Who's making this call and why?
Colin King writes Value Don't Lie on spin-offs, stubs and special situations. On our scoreboard he is 11-8 (.579) on 19 scored career calls, average edge about +35.1 points, median +4.2, last 10 at 4-6.
His Dauch path: February 2026 Quick Value piece with a $5 low / $10 high framing; July 24 "favorite asymmetric special situation"; October pushback on BofA. The stock has drifted near the low end of that February band.
Other supporters:
- Alex Roepers (Atlantic Investment Management) discussed Dauch as a deep-value special situation on a June 2026 Yet Another Value Podcast episode (episode notes disclose a long).
- The Value Pond (@TheValuePond) after Q2 said Dauch was showing a glimpse of the business once Dowlais is integrated.
- TD Cowen had a Buy/$10 target in September per secondary reports we flagged in an earlier draft; confirm against the firm's own note.
Who disagrees?
- BofA Securities: Underperform with a $5 target in mid-October, citing softer Ram heavy-duty production and estimated Q3 EBITDA pressure.
- Company guide: Full-year Adj. EBITDA ceiling cut by $50 million at the high end.
- Balance-sheet bears: Net leverage still elevated after the Dowlais deal; almost all enterprise value is debt if equity stays near $1.1 billion.
What are the key facts to verify on November 6?
- Final Q3 Adj. EBITDA versus the $355 million to $360 million preview.
- Synergy run-rate versus the more-than-$100 million year-end goal ($70 million as of the Q2 update).
- Net leverage and adjusted free cash flow versus prior ranges.
- Any change to the $300 million year-three synergy target.
What would prove it right or wrong?
Signals the long case is working:
- Synergies re-accelerate toward the year-one goal and free cash flow funds deleveraging.
- FY26 Adj. EBITDA holds the new band without another cut.
Signals it is failing:
- Another guide cut, synergy slippage, or free cash flow after restructuring staying near zero into 2027.
This is journalism and commentary, not investment advice. We hold no position unless stated.
